Related Experiment Videos
[Prostate cancer: palpation versus ultrasonography]
1Urologická klinika LF UPJS, Kosice.
Summary
Transrectal ultrasound (TRUS) offers superior accuracy in diagnosing prostate cancer compared to palpation and transabdominal ultrasound. TRUS is recommended as a supplementary screening tool after digital rectal examination and PSA testing.
Area of Science:
- Urology
- Oncology
- Medical Imaging
Background:
- Prostate cancer diagnosis relies on various methods, including physical examination and imaging.
- Ultrasound (USG) offers different modalities for prostate assessment: transabdominal and transrectal.
- Comparing the diagnostic efficacy of these methods is crucial for clinical practice.
Purpose of the Study:
- To compare the diagnostic effectiveness of palpation, transabdominal ultrasound (USG), and transrectal ultrasound (USG) for prostate carcinoma.
- To evaluate the accuracy of each diagnostic method against histopathological findings.
Main Methods:
- A comparative study involving symptomatic patients undergoing prostate examinations.
- Group 1: Palpation vs. transabdominal USG (n=273).
- Group 2: Palpation vs. transrectal USG (n=162).
- Histopathological correlation was obtained for a subset of patients (n=203).
Main Results:
- Prostate cancer was confirmed in 25.3% of patients.
- Transrectal USG demonstrated higher sensitivity (97.7%) and overall accuracy (92.6%) compared to palpation (75.4% sensitivity, 84.2% accuracy) and transabdominal USG (78.3% sensitivity, 87.2% accuracy).
- Transrectal USG improved cancer staging accuracy for T2 and T3 tumors.
- USG had limitations in diagnosing incidental cancers in patients with benign prostatic hyperplasia (BPH).
Conclusions:
- Transrectal USG is a highly effective diagnostic tool for prostate cancer, surpassing palpation and transabdominal USG in accuracy.
- USG can aid in more precise cancer staging.
- Transrectal USG is recommended as a screening tool following digital rectal examination and Prostate-Specific Antigen (PSA) testing.